全球计算生物学市场规模、份额、趋势和成长分析报告（2026-2034）

预计计算生物学市场将从 2025 年的 78 亿美元成长到 2034 年的 247 亿美元，2026 年至 2034 年的复合年增长率为 13.67%。

随着先进计算技术日益融入生物学和医疗保健研究，全球计算生物学市场正经历快速成长。计算生物学利用演算法、数据建模和生物资讯学工具来分析复杂的生物数据，包括基因组和蛋白质组资讯。对个人化医疗和精准医疗保健日益增长的需求，正显着推动计算生物学解决方案在药物研发和生物技术开发中的应用。

人工智慧、机器学习和高效能运算等技术的进步正在变革生物数据分析。这些技术使研究人员能够更有效率地处理海量体学数据并模拟生物系统。临床研究的增加和製药业研发活动的扩展也推动了全球计算生物学市场的成长。

随着药物研发日益数据主导，个人化治疗方案的重要性也日益凸显，预计市场将迎来强劲成长。生命科学研发投入的增加，以及云端生物资讯平台的发展，将进一步推动市场扩张。随着计算工具的不断发展，它们有望在加速医学研究和改善医疗效果方面发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球计算生物学市场：按应用划分

• 市场分析、洞察与预测
• 细胞和生物模拟
• 计算基因组学
• 计算蛋白质体学
• 药物基因体学
• 其他的

第五章：全球计算生物学市场：依工具划分

• 市场分析、洞察与预测
• 资料库
• 软体
• 服务

第六章 全球计算生物学市场：依最终用户划分

• 市场分析、洞察与预测
• 学术机构
• 产业
• 政府
• 其他的

第七章 全球计算生物学市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc
  • Dassault SystAfA¨Mes SE
  • Genedata AG
  • Chemical Computing Group ULC
  • Certara LP
  • SchrA¶Dinger Inc
  • Simulation Plus Inc
  • Insilico Medicine Inc
  • Compugen Ltd

The Computational Biology Market size is expected to reach USD 24.70 Billion in 2034 from USD 7.80 Billion (2025) growing at a CAGR of 13.67% during 2026-2034.

The global computational biology market is experiencing rapid growth as advanced computing technologies are increasingly integrated into biological and medical research. Computational biology uses algorithms, data modeling, and bioinformatics tools to analyze complex biological data, including genomic and proteomic information. The rising demand for personalized medicine and precision healthcare is significantly boosting the adoption of computational biology solutions in pharmaceutical research and biotechnology development.

Technological advancements such as artificial intelligence, machine learning, and high-performance computing are transforming biological data analysis. These technologies enable researchers to process large volumes of omics data and simulate biological systems more efficiently. The increasing number of clinical studies and growing pharmaceutical R&D activities are also contributing to the expansion of the computational biology market worldwide.

Looking ahead, the market is expected to witness strong growth as drug discovery becomes more data-driven and personalized treatment approaches gain importance. Expanding investments in life sciences research and the development of cloud-based bioinformatics platforms will further support market expansion. As computational tools continue to evolve, they are expected to play a critical role in accelerating medical research and improving healthcare outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Cellular and Biological Simulation
• Computational Genomics
• Computational Proteomics
• Pharmacogenomics
• Others

By Tools

• Databases
• Software
• Services

By End-User

• Academics
• Industry
• Government
• Others

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Dassault Systmes SE, Genedata AG, Chemical Computing Group ULC, Certara LP, Schrdinger Inc, Simulation Plus Inc, Insilico Medicine Inc, Compugen Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Cellular and Biological Simulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Computational Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Computational Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY TOOLS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Tools
• 5.2. Databases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Academics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Government Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application
  • 7.2.2 By Tools
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application
  • 7.3.2 By Tools
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application
  • 7.4.2 By Tools
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application
  • 7.5.2 By Tools
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application
  • 7.6.2 By Tools
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL COMPUTATIONAL BIOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Illumina Inc
  • 9.2.2 Thermo Fisher Scientific Inc
  • 9.2.3 Agilent Technologies Inc
  • 9.2.4 Dassault SystAfA¨Mes SE
  • 9.2.5 Genedata AG
  • 9.2.6 Chemical Computing Group ULC
  • 9.2.7 Certara L.P
  • 9.2.8 SchrA¶Dinger Inc
  • 9.2.9 Simulation Plus Inc
  • 9.2.10 Insilico Medicine Inc
  • 9.2.11 Compugen Ltd